​

Nevro (NVRO) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

NVRO Stock Forecast

Nevro (NVRO) stock forecast, based on 27 Wall Street analysts, predicts a 12-month average price target of $4.00, with a high of $4.00 and a low of $4.00. This represents a -31.51% decline from the last price of $5.84.

- $5 $10 $15 $20 $25 High: $4 Avg: $4 Low: $4 Last Closed Price: $5.84

NVRO Stock Rating

Nevro stock's rating consensus is Hold, based on 27 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 9 Buy (33.33%), 15 Hold (55.56%), 3 Sell (11.11%), and 0 Strong Sell (0.00%).

Hold
Total 27 0 3 15 9 Strong Sell Sell Hold Buy Strong Buy

NVRO Price Target Upside V Benchmarks

TypeNameUpside
StockNevro-31.51%
SectorHealthcare Stocks 35.94%
IndustryMedical Device Stocks21.01%

Price Target Trends

1M3M12M
# Anlaysts--8
Avg Price Target--$6.11
Last Closing Price$5.84$5.84$5.84
Upside/Downside--4.62%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 25--12-113
Mar, 25--12-113
Feb, 25--112316
Jan, 25--112316
Dec, 24--112316
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Dec 02, 2024Kallum TitchmarshMorgan Stanley$4.00$4.44-9.91%-31.51%
Oct 15, 2024David RescottRobert W. Baird$5.00$4.921.63%-14.38%
Aug 08, 2024Joanna WuenschCitigroup$6.89$5.6721.52%17.98%
Aug 08, 2024Richard NewitterTruist Financial$5.50$5.088.27%-5.82%
Aug 07, 2024David RescottRobert W. Baird$8.00$5.0060.00%36.99%
Aug 07, 2024Matthew TaylorJefferies$7.00$4.8344.93%19.86%
Aug 07, 2024Adam MaederPiper Sandler$7.00$8.69-19.45%19.86%
Aug 07, 2024Nathan TreybeckWells Fargo$5.50$8.69-36.71%-5.82%
Apr 11, 2024Anthony PetroneMizuho Securities$16.00$13.2820.48%173.97%
Apr 08, 2024Nathan TreybeckWells Fargo$14.00$13.295.34%139.73%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Dec 11, 2024CitigroupNeutralNeutralhold
Dec 02, 2024Morgan StanleyOverweightUnderweightdowngrade
Aug 08, 2024CitigroupSellNeutralupgrade
Aug 08, 2024Wolfe ResearchPeer Performupgrade
Aug 07, 2024JefferiesUnderperformUnderperformhold
Aug 07, 2024Piper SandlerUnderweightUnderweighthold
Aug 07, 2024Wells FargoEqual-WeightUnderweightdowngrade
Aug 07, 2024JMP SecuritiesPerformMarket Performdowngrade
Aug 07, 2024JMP SecuritiesPerformdowngrade
Jul 10, 2024CitigroupSellSellhold

Financial Forecast

EPS Forecast

$-4 $-3 $-2 $-1 $0 $1 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-2.47$-3.77$0.09$-2.56$-3.06----
Avg Forecast$-2.60$-3.65$0.11$-2.81$-2.44$-2.47$-2.15$-1.80$-1.52
High Forecast$-2.49$-3.50$0.12$-2.74$-2.29$-1.87$-1.30$-1.30$-1.41
Low Forecast$-2.68$-3.76$0.11$-2.90$-2.64$-2.93$-2.73$-2.07$-1.58
Surprise %-5.00%3.29%-18.18%-8.90%25.41%----

Revenue Forecast

$300M $340M $380M $420M $460M $500M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$362.05M$386.90M$406.37M$425.17M$408.52M----
Avg Forecast$359.60M$384.05M$405.98M$421.59M$404.31M$406.36M$423.07M$448.72M$480.35M
High Forecast$367.59M$392.58M$414.38M$421.66M$408.74M$417.85M$423.37M$449.22M$494.69M
Low Forecast$348.33M$372.01M$389.86M$421.38M$402.71M$384.09M$422.76M$448.22M$452.97M
Surprise %0.68%0.74%0.09%0.85%1.04%----

Net Income Forecast

$-200M $-150M $-100M $-50M $0 $50M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-83.06M$-131.36M$3.00M$-92.21M$-113.44M----
Avg Forecast$-104.90M$-125.15M$-152.03M$-92.21M$-88.68M$-93.04M$-82.41M$-69.85M$-54.69M
High Forecast$-83.92M$-100.12M$-121.62M$-73.77M$-82.45M$-67.21M$-46.95M$-46.74M$-50.64M
Low Forecast$-125.88M$-150.18M$-182.43M$-110.66M$-94.90M$-105.42M$-98.24M$-74.55M$-56.82M
Surprise %-20.82%4.97%-101.97%-27.93%----

NVRO Forecast FAQ

Is Nevro stock a buy?

Nevro stock has a consensus rating of Hold, based on 27 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 9 Buy, 15 Hold, 3 Sell, and 0 Strong Sell, reflecting a consensus that Nevro is a neutral investment for most analysts.

What is Nevro's price target?

Nevro's price target, set by 27 Wall Street analysts, averages $4 over the next 12 months. The price target range spans from $4 at the low end to $4 at the high end, suggesting a potential -31.51% change from the previous closing price of $5.84.

How does Nevro stock forecast compare to its benchmarks?

Nevro's stock forecast shows a -31.51% downside, underperforming the average forecast for the healthcare stocks sector (35.94%) and underperforming the medical device stocks industry (21.01%).

What is the breakdown of analyst ratings for Nevro over the past three months?

  • April 2025: 0% Strong Buy, 0% Buy, 92.31% Hold, 0% Sell, 7.69% Strong Sell.
  • March 2025: 0% Strong Buy, 0% Buy, 92.31% Hold, 0% Sell, 7.69% Strong Sell.
  • February 2025: 0% Strong Buy, 0% Buy, 68.75% Hold, 12.50% Sell, 18.75% Strong Sell.

What is Nevro’s EPS forecast?

Nevro's average annual EPS forecast for its fiscal year ending in December 2025 is $-2.47, marking a -19.28% decrease from the reported $-3.06 in 2024. Estimates for the following years are $-2.15 in 2026, $-1.8 in 2027, and $-1.52 in 2028.

What is Nevro’s revenue forecast?

Nevro's average annual revenue forecast for its fiscal year ending in December 2025 is $406.36M, reflecting a -0.53% decrease from the reported $408.52M in 2024. The forecast for 2026 is $423.07M, followed by $448.72M for 2027, and $480.35M for 2028.

What is Nevro’s net income forecast?

Nevro's net income forecast for the fiscal year ending in December 2025 stands at $-93.037M, representing a -17.98% decrease from the reported $-113M in 2024. Projections indicate $-82.41M in 2026, $-69.85M in 2027, and $-54.692M in 2028.